[1] PIKE KE, CAVUOTO MG, LI L, et al. Subjective Cognitive Decline: Level of Risk for Future Dementia and Mild Cognitive Impairment, a Meta-Analysis of Longitudinal Studies. Neuropsychol Rev. 2022;32(4):703-735.
[2] CHEN X, CAO M, LIU M, et al. Association between sarcopenia and cognitive impairment in the older people: a meta-analysis. Eur Geriatr Med. 2022;13(4):771-787.
[3] CHOWDHARY N, BARBUI C, ANSTEY KJ, et al. Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations. Front Neurol. 2022;12:765584.
[4] SEBASTIAN MJ, KHAN SK, PAPPACHAN JM, et al. Diabetes and cognitive function: An evidence-based current perspective. World J Diabetes. 2023;14(2):92-109.
[5] ALDRICH L, ISPOGLOU T, PROKOPIDIS K, et al. Acute Sarcopenia: Systematic Review and Meta-Analysis on Its Incidence and Muscle Parameter Shifts During Hospitalisation. J Cachexia Sarcopenia Muscle. 2025;16(1):e13662.
[6] ALVES FM, AYTON S, BUSH AI, et al. Age-Related Changes in Skeletal Muscle Iron Homeostasis. J Gerontol A Biol Sci Med Sci. 2023;78(1):16-24.
[7] SAYER AA, COOPER R, ARAI H, et al. Sarcopenia. Nat Rev Dis Primers. 2024;10(1):68.
[8] LEE DY. Prevalence and Associated Factors of Dynapenia, Pre-Sarcopenia, and Sarcopenia in Korean Adults: A Cross-Sectional Epidemiological Study. Medicina (Kaunas). 2025;61(4):575.
[9] AMINI N, IBN HACH M, LAPAUW L, et al. Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer’s disease and other forms of dementia. J Cachexia Sarcopenia Muscle. 2024;15(4):1240-1253.
[10] YANG Y, XIAO M, LENG L, et al. A systematic review and meta-analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia. J Cachexia Sarcopenia Muscle. 2023;14(1):45-56.
[11] HUANG J, LI M, LUO Q, et al. The association of sarcopenia, possible sarcopenia and cognitive impairment: A systematic review and meta-analysis. PLoS One. 2025;20(5):e0324258.
[12] WANG X, XIAO R, LI H, et al. Correlation between Mild Cognitive Impairment and Sarcopenia: The Prospective Role of Lipids and Basal Metabolic Rate in the Link. Nutrients. 2022;14(24):5321.
[13] YUAN S, LARSSON SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.
[14] SEVERINSEN MCK, PEDERSEN BK. Muscle-Organ Crosstalk: The Emerging Roles of Myokines. Endocr Rev. 2020;41(4):594-609.
[15] HU Y, PENG W, REN R, et al. Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS. J Cachexia Sarcopenia Muscle. 2022;13(6):2944-2952.
[16] CIPOLLI GC, DE ASSUMPÇÃO D, BORIM FSA, et al. Cognitive Impairment Predicts Sarcopenia 9 Years Later among Older Adults. J Am Med Dir Assoc. 2023;24(8):1207-1212.
[17] RAMOO K, HAIRI NN, YAHYA A, et al. Longitudinal Association between Sarcopenia and Cognitive Impairment among Older Adults in Rural Malaysia. Int J Environ Res Public Health. 2022;19(8):4723.
[18] SHARMA N, SRIVASTAV AK, SAMUEL AJ, et al. Randomized clinical trial: gold standard of experimental designs-importance, advantages, disadvantages and prejudices. Revista Pesquisa em Fisioterapia. 2020;10(3):512-519.
[19] LARSSON SC, BUTTERWORTH AS, BURGESS S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913-4924.
[20] DENG MG, LIU F, LIANG Y, et al. Association between frailty and depression: A bidirectional Mendelian randomization study. Sci Adv. 2023; 9(38):eadi3902.
[21] PEI YF, LIU YZ, YANG XL, et al. The genetic architecture of appendicular lean mass characterized by association analysis in the UK Biobank study. Commun Biol. 2020; 3(1):608.
[22] JONES G, TRAJANOSKA K, SANTANASTO AJ, et al. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women. Nat Commun. 2021;12(1):654.
[23] HU MJ, TAN JS, GAO XJ, et al. Effect of Cheese Intake on Cardiovascular Diseases and Cardiovascular Biomarkers. Nutrients. 2022; 14(14):2936.
[24] YANG H, CHEN L, LIU Y. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis. J Clin Endocrinol Metab. 2023;108(2):433-442.
[25] LIU C, LIU N, XIA Y, et al. Osteoporosis and sarcopenia-related traits: A bi-directional Mendelian randomization study. Front Endocrinol (Lausanne). 2022;13:975647.
[26] HE J, HUANG M, LI N, et al. Genetic Association and Potential Mediators between Sarcopenia and Coronary Heart Disease: A Bidirectional Two-Sample, Two-Step Mendelian Randomization Study. Nutrients. 2023;15(13):3013.
[27] DU Y, XIE B, WANG M, et al. Roles of sex hormones in mediating the causal effect of vitamin D on osteoporosis: A two-step Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1159241.
[28] SU Q, JIN C, YANG Y, et al. Association Between Autoimmune Diseases and Sarcopenia: A Two-Sample Mendelian Randomization Study. Clin Epidemiol. 2023;15:901-910.
[29] ZHOU S, TAO B, GUO Y, et al. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. J Transl Med. 2024;22(1):557.
[30] NI JJ, XU Q, YAN SS, et al. Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study. Front Microbiol. 2022;12: 737197.
[31] KARAGEORGIOU V, TYRRELL J, MCKINLEY TJ, et al. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings. Genet Epidemiol. 2023; 47(2):135-151.
[32] DING M, ZHANG Z, CHEN Z, et al. Association between periodontitis and breast cancer: two-sample Mendelian randomization study. Clin Oral Investig. 2023;27(6):2843-2849.
[33] KJAERGAARD AD, TEUMER A, WITTE DR, et al. Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study. Clin Chem. 2022;68(3):461-472.
[34] PENG TC, CHEN WL, WU LW, et al. Sarcopenia and cognitive impairment: A systematic review and meta-analysis. Clin Nutr. 2020;39(9):2695-2701.
[35] XIN X, LIU Q, JIA S, et al. Correlation of muscle strength, information processing speed and cognitive function in the elderly with cognitive impairment-evidence from EEG. Front Aging Neurosci. 2025;17: 1496725.
[36] KIM K, KIM H. Handgrip Strength and Cognitive Function among Elderly Koreans: Insights from the Korean Longitudinal Study of Ageing. Int J Environ Res Public Health. 2022;19(9):5262.
[37] CHEN KK, LEE SY, PANG BWJ, et al. Associations of low handgrip strength and hand laterality with cognitive function and functional mobility - the Yishun Study. BMC Geriatr. 2022;22(1):677.
[38] AUYEUNG TW, KWOK T, LEE J, et al. Functional decline in cognitive impairment--the relationship between physical and cognitive function. Neuroepidemiology. 2008;31(3):167-173.
[39] XIE X, LI D, ZHOU M, et al. Effects of Hand Strength and Walking Speed Combined and in Isolation on the Prediction of Cognitive Decline and Dementia in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2025;26(6):105576.
[40] LI H, ZHANG J, ZOU X, et al. The Bidirectional Association Between Cognitive Function and Gait Speed in Chinese Older Adults: Longitudinal Observational Study. JMIR Public Health Surveill. 2023;9:e44274.
[41] SKILLBÄCK T, BLENNOW K, ZETTERBERG H, et al. Slowing gait speed precedes cognitive decline by several years. Alzheimers Dement. 2022;18(9): 1667-1676.
[42] TESSIER AJ, WING SS, RAHME E, et al. Association of Low Muscle Mass With Cognitive Function During a 3-Year Follow-up Among Adults Aged 65 to 86 Years in the Canadian Longitudinal Study on Aging. JAMA Netw Open. 2022;5(7):e2219926.
[43] MERCHANT RA, SEETHARAMAN S, AU L, et al. Relationship of Fat Mass Index and Fat Free Mass Index With Body Mass Index and Association With Function, Cognition and Sarcopenia in Pre-Frail Older Adults. Front Endocrinol (Lausanne). 2021;12:765415.
[44] SUI SX, WILLIAMS LJ, HOLLOWAY-KEW KL, et al. Skeletal Muscle Health and Cognitive Function: A Narrative Review. Int J Mol Sci. 2020;22(1):255.
[45] AUYEUNG TW, LEE JS, KWOK T, et al. Physical frailty predicts future cognitive decline - a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging. 2011;15(8):690-694.
[46] YE JY, CHANG LF, CHEN R, et al. Prevalence of sarcopenia in middle-aged and older adults with cognitive impairment: a meta-analysis. Age Ageing. 2025;54(5):afaf114.
[47] ZENG D, MIZUTANI K, QI X, et al. The association of hemopexin, muscle quality, and sarcopenia in Japanese older adults with cognitive impairment: a cross-sectional study. BMC Geriatr. 2025;25(1):332.
[48] OUDBIER SJ, GOH J, LOOIJAARD SMLM, et al. Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function. J Gerontol A Biol Sci Med Sci. 2022;77(10):1959-1968.
[49] VAN DAM R, VAN ANCUM JM, VERLAAN S, et al. Lower Cognitive Function in Older Patients with Lower Muscle Strength and Muscle Mass. Dement Geriatr Cogn Disord. 2018;45(3-4):243-250.
[50] OGAWA Y, KANEKO Y, SATO T, et al. Sarcopenia and Muscle Functions at Various Stages of Alzheimer Disease. Front Neurol. 2018;9:710.
[51] INYUSHKIN AN, POLETAEV VS, INYUSHKINA EM, et al. Irisin/BDNF signaling in the muscle-brain axis and circadian system: A review. J Biomed Res. 2023;38(1):1-16.
[52] WANG Y, ZHANG Y, WANG X, et al. Sesamol Mitigates Chronic Iron Overload-Induced Cognitive Impairment and Systemic Inflammation via IL-6 and DMT1 Regulation. Mol Nutr Food Res. 2023;67(17):e2300012.
[53] TANG L, XIE D, WANG S, et al. Piezo1 Knockout Improves Post-Stroke Cognitive Dysfunction by Inhibiting the Interleukin-6 (IL-6)/Glutathione Peroxidase 4 (GPX4) Pathway. J Inflamm Res. 2024;17:2257-2270.
[54] TEGELER C, O’SULLIVAN JL, BUCHOLTZ N, et al. The inflammatory markers CRP, IL-6, and IL-10 are associated with cognitive function--data from the Berlin Aging Study II. Neurobiol Aging. 2016;38:112-117.
[55] KERKIS I, DA SILVA ÁP, ARALDI RP. The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions. Front Immunol. 2024;15:1400533.
[56] LIU PZ, NUSSLOCK R. Exercise-Mediated Neurogenesis in the Hippocampus via BDNF. Front Neurosci. 2018;12:52.
[57] CAMUSO S, LA ROSA P, FIORENZA MT, et al. Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders. Neurobiol Dis. 2022;163:105606.
[58] RUIZ-GONZÁLEZ D, HERNÁNDEZ-MARTÍNEZ A, VALENZUELA PL, et al. Effects of physical exercise on plasma brain-derived neurotrophic factor in neurodegenerative disorders: A systematic review and meta-analysis of randomized controlled trials. Neurosci Biobehav Rev. 2021;128:394-405.
[59] LEGER C, QUIRIÉ A, MÉLOUX A, et al. Impact of Exercise Intensity on Cerebral BDNF Levels: Role of FNDC5/Irisin. Int J Mol Sci. 2024;25(2):1213.
[60] BAEK JY, JANG IY, JUNG HW, et al. Serum irisin level is independent of sarcopenia and related muscle parameters in older adults. Exp Gerontol. 2022;162:111744.
[61] GULLETT JM, CHEN Z, O’SHEA A, et al. MicroRNA predicts cognitive performance in healthy older adults. Neurobiol Aging. 2020;95:186-194.
[62] ALCHUS LAIFEROVÁ N, VERNEROVÁ L, NEMEC M, et al. Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training. Rheumatology (Oxford). 2025;64(7):4347-4356.
[63] BIESEMANN N, RIED JS, DING-PFENNIGDORFF D, et al. High throughput screening of mitochondrial bioenergetics in human differentiated myotubes identifies novel enhancers of muscle performance in aged mice. Sci Rep. 2018;8(1):9408.
|